Dongying Tiandong Pharmaceutical Co.,Ltd

Form 483 issued October 19, 2018 · Dongying, China

Inspection
Oct 15 – Oct 19, 2018
Investigator
Marijo B. Kambere
Observations
2
Pages
2
FEI number
3004395180

In short: On October 19, 2018, FDA issued a Form 483 with 2 observations to Dongying Tiandong Pharmaceutical Co.,Ltd in Dongying, Shandong (FEI 3004395180) after an inspection that ran Oct 15 – Oct 19, 2018. The investigator was Marijo B. Kambere. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.194 (laboratory records).

At a glance

Observations span 1 system, led by laboratory controls.

Laboratory controls1
Other1

Most cited: 21 CFR 211.194 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Documentation and records are…

  2. 02

    Laboratory control records are…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Dongying Tiandong Pharmaceutical Co.,Ltd?

FDA listed 2 observations on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.194 (laboratory records). The opening words of each observation are shown on this page.

Who inspected Dongying Tiandong Pharmaceutical Co.,Ltd?

Marijo B. Kambere is named on this Form 483, for the inspection of Oct 15 – Oct 19, 2018. Each investigator has a profile showing what they cite most.

When was Dongying Tiandong Pharmaceutical Co.,Ltd inspected by FDA?

The inspection ran Oct 15 – Oct 19, 2018, and the Form 483 is dated October 19, 2018.

How do I get the full Form 483 for Dongying Tiandong Pharmaceutical Co.,Ltd?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free